核心类别:SCIE(2022版), 目次收录(超星), 目次收录(知网),外文期刊, 投稿网址:cir.msubmit.net/ 期刊网址:cancerimmunolres.aacrjournals.org 所属分区:1区 是否TOP:TOP期刊 是否综述:非综述期刊 是否OA:非OA期刊 期刊简介:CANCER IMMUNOLOGY RESEARCH《癌症免疫学研究》(月刊). Cancer Immunology Research publish...
E. et al. Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survival. Cancer Immunol. Res. 2, 981–987 (2014). Article CAS PubMed PubMed Central Google Scholar Oh, J. et al. Phase II...
Sin. B 12, 787–800 (2022). Article CAS PubMed Google Scholar You, W. et al. Farnesoid X receptor constructs an immunosuppressive microenvironment and sensitizes FXRhighPD-L1low NSCLC to anti-PD-1 immunotherapy. Cancer Immunol. Res. 7, 990–1000 (2019). Article CAS PubMed Google ...
Furthermore, Dan lu and his team found that the activation of EGR1 (redox transcription factor) mediated by oxidative stress generally induces the expression of PAC1 at a high rate in CD8+T cells within the tumor microenvironment. Next, the upregulation of PAC1 triggers the recruitment of Mi...
Pharm Res 23:1574–1585 Article CAS PubMed Google Scholar Workman CJ, Dugger KJ, Vignali DA (2002) Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3. J Immunol 169:5392–5395 Article CAS PubMed Google Scholar Wu X, Peng M, Huang B, ...
Immunol Rev. 2012;246(1):379–400. Google Scholar Liotti F, Visciano C, Melillo RM. Inflammation in thyroid oncogenesis. Am J Cancer Res. 2012;2(3):286–97. Google Scholar Maccio A, Madeddu C. Inflammation and ovarian cancer. Cytokine. 2012;58(2):133–47. CAS Google Scholar ...
Interleukin-2 (IL-2) and its receptor (IL-2R) are essential in orchestrating immune responses. Their function and expression in the tumor microenvironment make them attractive targets for immunotherapy, leading to the development of IL-2/IL-2R-targeted t
Cancer Immunol Res. 2021;9(12):1383–99. CAS PubMed Google Scholar Meng X, Zhao Y, Han B, Zha C, Zhang Y, Li Z, Wu P, Qi T, Jiang C, Liu Y, et al. Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling ...
T-cell-based immunotherapies are promising treatments for cancer patients. Although durable responses can be achieved in some patients, many patients fail to respond to these therapies, underscoring the need for improvement with combination therapies. Fr
Cancer Immunol. Res. 6, 422–433 (2018). Article CAS PubMed PubMed Central Google Scholar Demaria, O. et al. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proc. Natl Acad. Sci. USA 112, 15408–15413 (2015). Article CAS PubMed Pub...